nitrates has been researched along with Liver Steatosis in 14 studies
Nitrates: Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the potential of S-nitroso-N-acetylcysteine (SNAC) in inhibition of lipid peroxidation and the effect of oral SNAC administration in the prevention of nonalcoholic fatty liver disease (NAFLD) in an animal model." | 7.73 | Oral administration of S-nitroso-N-acetylcysteine prevents the onset of non alcoholic fatty liver disease in rats. ( Abdalla, DS; Alves, VA; Carrilho, FJ; de Lima, VM; de Oliveira, CP; de Oliveira, MG; Laurindo, FR; Lopasso, FP; Simplicio, FI; Yuahasi, K, 2006) |
| " l-Arginine improved hepatic arterial and portal blood flows as well as microcirculation in fatty livers (P < 0." | 3.73 | The role of nitric oxide in the modulation of hepatic microcirculation and tissue oxygenation in an experimental model of hepatic steatosis. ( Ijaz, S; Seifalian, AM; Winslet, MC; Yang, W, 2005) |
| "To evaluate the potential of S-nitroso-N-acetylcysteine (SNAC) in inhibition of lipid peroxidation and the effect of oral SNAC administration in the prevention of nonalcoholic fatty liver disease (NAFLD) in an animal model." | 3.73 | Oral administration of S-nitroso-N-acetylcysteine prevents the onset of non alcoholic fatty liver disease in rats. ( Abdalla, DS; Alves, VA; Carrilho, FJ; de Lima, VM; de Oliveira, CP; de Oliveira, MG; Laurindo, FR; Lopasso, FP; Simplicio, FI; Yuahasi, K, 2006) |
| "Nonalcoholic fatty liver disease is a chronic metabolic disorder with significant impact on cardiovascular and liver mortality." | 1.38 | Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis. ( Bucchieri, F; Bugianesi, E; Galvano, F; Li Volti, G; Mangiameli, A; Marino Gammazza, A; Marino, A; Parola, M; Paternostro, C; Salamone, F; Tibullo, D, 2012) |
| "In addition, this treatment improved fatty liver, decreased hepatic triglyceride concentration and increased apolipoprotein B100 in liver tissue." | 1.37 | Melatonin improves mitochondrial respiratory chain activity and liver morphology in ob/ob mice. ( Fernández-Moreira, D; García Ruiz, I; García-Consuegra, I; Gómez-Izquierdo, E; Muñoz-Yagüe, T; Solís-Herruzo, JA; Solís-Muñoz, P, 2011) |
| "The pathogenesis of nonalcoholic steatohepatitis (NASH) is still unclear." | 1.36 | Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, l-amino acid-defined diet-fed rat model. ( Fujita, K; Inamori, M; Iwasaki, T; Kirikoshi, H; Maeyama, S; Nakajima, A; Nozaki, Y; Saito, S; Takahashi, H; Terauchi, Y; Wada, K; Yoneda, M, 2010) |
| " Amiodarone led to a dose-dependent decrease in cell viability with an LD50 of 50 micromol/L and increased production of superoxide anion and lipid peroxidation." | 1.34 | Combining ursodeoxycholic acid or its NO-releasing derivative NCX-1000 with lipophilic antioxidants better protects mouse hepatocytes against amiodarone toxicity. ( Chabli, A; Colin, P; Elimadi, A; Haddad, PS; Ouazzani-Chahdi, A; Spénard, J, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (21.43) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Namwong, A | 1 |
| Kumphune, S | 1 |
| Seenak, P | 1 |
| Chotima, R | 1 |
| Nernpermpisooth, N | 1 |
| Malakul, W | 1 |
| Cordero-Herrera, I | 1 |
| Kozyra, M | 1 |
| Zhuge, Z | 1 |
| McCann Haworth, S | 1 |
| Moretti, C | 1 |
| Peleli, M | 1 |
| Caldeira-Dias, M | 1 |
| Jahandideh, A | 1 |
| Huirong, H | 1 |
| Cruz, JC | 1 |
| Kleschyov, AL | 1 |
| Montenegro, MF | 1 |
| Ingelman-Sundberg, M | 1 |
| Weitzberg, E | 1 |
| Lundberg, JO | 1 |
| Carlstrom, M | 1 |
| Fujita, K | 1 |
| Nozaki, Y | 1 |
| Yoneda, M | 1 |
| Wada, K | 1 |
| Takahashi, H | 1 |
| Kirikoshi, H | 1 |
| Inamori, M | 1 |
| Saito, S | 1 |
| Iwasaki, T | 1 |
| Terauchi, Y | 1 |
| Maeyama, S | 1 |
| Nakajima, A | 1 |
| Rensen, SS | 1 |
| Slaats, Y | 1 |
| Nijhuis, J | 1 |
| Jans, A | 1 |
| Bieghs, V | 1 |
| Driessen, A | 1 |
| Malle, E | 1 |
| Greve, JW | 1 |
| Buurman, WA | 1 |
| Solís-Muñoz, P | 1 |
| Solís-Herruzo, JA | 1 |
| Fernández-Moreira, D | 1 |
| Gómez-Izquierdo, E | 1 |
| García-Consuegra, I | 1 |
| Muñoz-Yagüe, T | 1 |
| García Ruiz, I | 1 |
| Tirapelli, LF | 1 |
| Batalhão, ME | 1 |
| Jacob-Ferreira, AL | 1 |
| Tirapelli, DP | 1 |
| Carnio, EC | 1 |
| Tanus-Santos, JE | 1 |
| Queiroz, RH | 1 |
| Uyemura, SA | 1 |
| Padovan, CM | 1 |
| Tirapelli, CR | 1 |
| Salamone, F | 1 |
| Galvano, F | 1 |
| Marino Gammazza, A | 1 |
| Marino, A | 1 |
| Paternostro, C | 1 |
| Tibullo, D | 1 |
| Bucchieri, F | 1 |
| Mangiameli, A | 1 |
| Parola, M | 1 |
| Bugianesi, E | 1 |
| Li Volti, G | 1 |
| Liu, Q | 1 |
| Rehman, H | 1 |
| Krishnasamy, Y | 1 |
| Ramshesh, VK | 1 |
| Theruvath, TP | 1 |
| Chavin, KD | 1 |
| Schnellmann, RG | 1 |
| Lemasters, JJ | 1 |
| Zhong, Z | 1 |
| Ijaz, S | 1 |
| Yang, W | 1 |
| Winslet, MC | 1 |
| Seifalian, AM | 1 |
| de Oliveira, CP | 1 |
| Simplicio, FI | 1 |
| de Lima, VM | 1 |
| Yuahasi, K | 1 |
| Lopasso, FP | 1 |
| Alves, VA | 1 |
| Abdalla, DS | 1 |
| Carrilho, FJ | 1 |
| Laurindo, FR | 1 |
| de Oliveira, MG | 1 |
| Ouazzani-Chahdi, A | 1 |
| Elimadi, A | 1 |
| Chabli, A | 1 |
| Spénard, J | 1 |
| Colin, P | 1 |
| Haddad, PS | 1 |
| Aivazian, LK | 1 |
| Archibald, RW | 1 |
| Orton, CC | 1 |
| Schüttmann, W | 1 |
| Ullmann, W | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Dapagliflozin on Cardio-Metabolic Risk Factors in Patients With Type-2 Diabetes[NCT03377335] | Phase 4 | 186 participants (Anticipated) | Interventional | 2017-12-22 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
14 other studies available for nitrates and Liver Steatosis
| Article | Year |
|---|---|
Pineapple fruit improves vascular endothelial dysfunction, hepatic steatosis, and cholesterol metabolism in rats fed a high-cholesterol diet.
Topics: Ananas; Animals; Antioxidants; Cholesterol; Cholesterol 7-alpha-Hydroxylase; Diet; Fatty Liver; Frui | 2022 |
AMP-activated protein kinase activation and NADPH oxidase inhibition by inorganic nitrate and nitrite prevent liver steatosis.
Topics: AMP-Activated Protein Kinases; Animals; Enzyme Activation; Fatty Liver; Hep G2 Cells; Hepatocytes; H | 2019 |
Nitric oxide plays a crucial role in the development/progression of nonalcoholic steatohepatitis in the choline-deficient, l-amino acid-defined diet-fed rat model.
Topics: Amino Acids; Animals; Blotting, Western; Choline; Choline Deficiency; Diet; Disease Models, Animal; | 2010 |
Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis.
Topics: Adult; Alcohols; Biomarkers; Cell Count; Chemokines, CXC; Fatty Liver; Female; Humans; Hypochlorous | 2009 |
Melatonin improves mitochondrial respiratory chain activity and liver morphology in ob/ob mice.
Topics: Animals; Blotting, Western; Body Weight; Electron Transport Chain Complex Proteins; Fatty Liver; His | 2011 |
Chronic ethanol consumption induces histopathological changes and increases nitric oxide generation in the rat liver.
Topics: Animals; Biomarkers; Ethanol; Fatty Liver; Gene Expression; Liver; Male; Malondialdehyde; Metallopro | 2011 |
Silibinin improves hepatic and myocardial injury in mice with nonalcoholic steatohepatitis.
Topics: Alanine Transaminase; Analysis of Variance; Animals; Antioxidants; Choline Deficiency; Cytokines; Di | 2012 |
Role of inducible nitric oxide synthase in mitochondrial depolarization and graft injury after transplantation of fatty livers.
Topics: Adenosine; Alanine Transaminase; Allopurinol; Amidines; Animals; Benzylamines; Bilirubin; Caspase 3; | 2012 |
The role of nitric oxide in the modulation of hepatic microcirculation and tissue oxygenation in an experimental model of hepatic steatosis.
Topics: Alanine Transaminase; Animals; Arginine; Aspartate Aminotransferases; Cholesterol; Electron Transpor | 2005 |
Oral administration of S-nitroso-N-acetylcysteine prevents the onset of non alcoholic fatty liver disease in rats.
Topics: Acetylcysteine; Administration, Oral; Animals; Disease Models, Animal; Fatty Liver; Lipid Peroxidati | 2006 |
Combining ursodeoxycholic acid or its NO-releasing derivative NCX-1000 with lipophilic antioxidants better protects mouse hepatocytes against amiodarone toxicity.
Topics: Amiodarone; Animals; Antioxidants; Ascorbic Acid; Butylated Hydroxytoluene; Cells, Cultured; Dose-Re | 2007 |
[Morphologic studies in the toxicologic and hygienic evaluation of nitrates].
Topics: Animals; Dose-Response Relationship, Drug; Fatty Liver; Liver; Nitrates; Rats | 1986 |
Specific identification of free and esterified fatty acids in tissue sections.
Topics: Adipose Tissue; Animals; Dioxins; Fatty Acids; Fatty Acids, Nonesterified; Fatty Liver; Histocytoche | 1970 |
[Effect of nitro lac solvents on the liver].
Topics: Chemical and Drug Induced Liver Injury; Coloring Agents; Environmental Exposure; Fatty Liver; Female | 1973 |